- Home
- BOLD vs COCH Comparison
BOLD vs COCH Comparison
Compare BOLD & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- COCH
- Stock Information
- Founded
- BOLD 2018
- COCH 1995
- Country
- BOLD United States
- COCH United States
- Employees
- BOLD N/A
- COCH N/A
- Industry
- BOLD
- COCH Blank Checks
- Sector
- BOLD
- COCH Finance
- Exchange
- BOLD Nasdaq
- COCH Nasdaq
- Market Cap
- BOLD 24.4M
- COCH 25.2M
- IPO Year
- BOLD 2024
- COCH N/A
- Fundamental
- Price
- BOLD $1.15
- COCH $1.34
- Analyst Decision
- BOLD Buy
- COCH Strong Buy
- Analyst Count
- BOLD 4
- COCH 2
- Target Price
- BOLD $4.00
- COCH $9.25
- AVG Volume (30 Days)
- BOLD 77.7K
- COCH 788.5K
- Earning Date
- BOLD 11-06-2025
- COCH 11-13-2025
- Dividend Yield
- BOLD N/A
- COCH N/A
- EPS Growth
- BOLD N/A
- COCH N/A
- EPS
- BOLD N/A
- COCH N/A
- Revenue
- BOLD N/A
- COCH $222,000.00
- Revenue This Year
- BOLD N/A
- COCH $4.27
- Revenue Next Year
- BOLD N/A
- COCH $23.37
- P/E Ratio
- BOLD N/A
- COCH N/A
- Revenue Growth
- BOLD N/A
- COCH N/A
- 52 Week Low
- BOLD $1.00
- COCH $1.06
- 52 Week High
- BOLD $4.72
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- BOLD 49.88
- COCH 51.22
- Support Level
- BOLD $1.13
- COCH $1.23
- Resistance Level
- BOLD $1.16
- COCH $1.37
- Average True Range (ATR)
- BOLD 0.04
- COCH 0.09
- MACD
- BOLD 0.00
- COCH 0.02
- Stochastic Oscillator
- BOLD 55.56
- COCH 84.85
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.